Tata Elxsi and Skanray Partner to Advance Surgical Imaging Technology

On August 6, 2024, Tata Elxsi Limited announced a strategic partnership with Skanray, a prominent global MedTech company specialising in diagnostic imaging, critical care, and surgical solutions. This collaboration is set to enhance surgical imaging core technology and software platform development, aiming to revolutionise diagnosis and treatment by incorporating advanced technology modules for greater predictability, accuracy, and consistency.

Skanray is focusing on expanding its portfolio to include new device families and modalities. This includes developing a suite of reusable modules and components for medical devices, as well as an advanced analytics cloud platform. Tata Elxsi will spearhead a software platform approach that will support all imaging, critical care, and surgical systems within the Skanray family, ensuring interoperability, compatibility, and multimodal functionality. The platform will integrate the latest advancements in AI and GenAI technologies.

By combining Skanray’s expertise in medical devices, core component technology, and systems with Tata Elxsi’s domain knowledge in medical imaging, software platform development, cloud, AI, and analytics, this partnership aims to transform the medical technology landscape. The collaboration will focus on creating advanced, modular, and cost-effective diagnostic systems.

Commenting on this partnership, the Head of Healthcare Business Unit at Tata Elxsi, Pankaj Madhukar Wani, said, “The diagnostic imaging landscape is being transformed by software and digital technologies such as cloud and AI. We are delighted to be supporting Skanray in realising their long-term strategy and vision for healthcare. This long-term partnership will help create transformative solutions for healthcare facilities and patients worldwide.”

The VP of Corporate Communications at Skanray Technologies Ltd, Priyanka Chatterjee, said, “By combining Skanray’s core technology and deep understanding of medical applications with Tata Elxsi’s capabilities in futuristic technology, we are poised to drive significant advancements in healthcare delivery. Our collaborative efforts will result in solutions that are not only technologically advanced but are also operator-friendly and cost-effective, helping healthcare providers deliver significantly improved health outcomes for patients.”

On August 06, 2024, the share price of Tata Elxsi Ltd opened at ₹6,777.80, touching the day’s high at ₹6,888.50, as of 11:53 AM on the NSE.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.